Skip to main content
Fig. 3 | BMC Gastroenterology

Fig. 3

From: Protocol for a randomized controlled multicenter trial assessing the efficacy of leuprorelin for severe polycystic liver disease: the AGAINST-PLD study

Fig. 3

Study design of the AGAINST-PLD study. Patients are randomized between direct and delayed start (after 18 months) of treatment. a Historical scan, b baseline scan, a, b historical growth. Primairy outcome, comparison between growth on treatment and without treatment in the first 18 months is b, c versus b, e. Secondary outcome, growth within individuals before and during treatment is b, c versus c, d and a, b versus b, e

Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us